Jonathan Yu
Chief Opearating OfficerMr. Jonathan Yu, MBA serves as Chief Operating Officer of Disc Medicine, Inc. since February 2024 and was its Chief Business Officer since August 2021 until February 2024. He was Senior Vice President of Corporate Development of Disc Medicine, Inc. from July 2020 to August 2021. He had overseen corporate strategy, business development and commercial strategy at Disc Medicine. Previously, he was a co-founder of Qpex Biopharma, where he served as the Vice President of Corporate Strategy, Finance and Operations from October 2018 to July 2020, where he led all its business functions including the spin-out of the core assets, its Series A financing and its partnerships. Before Qpex, he served in various leadership roles at The Medicines Company (July 2013 to July 2018), most recently as Vice President of Strategic Planning and Corporate Development, where he was instrumental in the divestiture of commercial-stage infectious disease assets to Melinta Therapeutics and the acquisition and subsequent integration of Rempex Pharmaceuticals. He has also held a variety of roles at SR One, Acceleron Pharma and Johnson & Johnson, spanning commercial planning and assessment, business development and finance. He holds an MBA from the Wharton School of the University of Pennsylvania and an BA in Biochemical Sciences from Harvard College.
Positions
- Company NameDisc Medicine, Inc.Stock CodeIRONPositionChief Opearating OfficerColleagues
- DWDonald William NicholsonExecutive Chairman
- JDJohn D. QuiselCEO, President & Director
- JMJean M. FranchiChief Financial Officer
- WJWilliam Jacob SavageChief Medical Officer
- BMBrian MacDonaldFounder & Chair of Scientific Advisory Board
- KJKevin J. BittermanIndependent Director
- WRWilliam R. WhiteIndependent Director
